Announced
Financials
Tags
United Kingdom
Majority
Pending
Biotechnology
Private
Friendly
Single Bidder
Acquisition
Private Equity
antibodies
Cross Border
Synopsis
Thompson Street Capital Partners-backed LifeSpan Biosciences, a biotechnology company, agreed to acquire Absolute Antibody, a manufacturer of recombinant antibodies. Financial terms were not disclosed. “We’re excited to be partnering with the founders and management team of Absolute Antibody. The Company highly complements our existing efforts in life science reagents through our platform LSBio," Bob Dunn, TSCP Managing Partner.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.